Cargando…
Dysfunctional cGMP Signaling Leads to Age-Related Retinal Vascular Alterations and Astrocyte Remodeling in Mice
The nitric oxide–guanylyl cyclase-1–cyclic guanylate monophosphate (NO–GC-1–cGMP) pathway is integral to the control of vascular tone and morphology. Mice lacking the alpha catalytic domain of guanylate cyclase (GC1(−/−)) develop retinal ganglion cell (RGC) degeneration with age, with only modest fl...
Autores principales: | Holden, Joseph M., Al Hussein Al Awamlh, Sara, Croteau, Louis-Philippe, Boal, Andrew M., Rex, Tonia S., Risner, Michael L., Calkins, David J., Wareham, Lauren K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954518/ https://www.ncbi.nlm.nih.gov/pubmed/35328488 http://dx.doi.org/10.3390/ijms23063066 |
Ejemplares similares
-
cGMP Signaling in the Neurovascular Unit—Implications for Retinal Ganglion Cell Survival in Glaucoma
por: Haider, Ameer A., et al.
Publicado: (2022) -
cGMP signaling: a potential therapeutic target for neurodegeneration in glaucoma?
por: Holden, Joseph M., et al.
Publicado: (2022) -
Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration
por: Al Hussein Al Awamlh, Sara, et al.
Publicado: (2021) -
Astrocyte Networks as Therapeutic Targets in Glaucomatous Neurodegeneration
por: Boal, Andrew M., et al.
Publicado: (2021) -
NO-dependent cGMP signalling in neurons and astrocytes
por: Giesen, Jan, et al.
Publicado: (2015)